September 24, 2012 — Bio DG announced that its patent for a novel metal system, to use as biodegradable material in developing implantable medical devices, was granted by the U.S. Patent Office on Aug. 21, 2012. Bio DG's biodegradable alloys are primarily metallic and provide high strength when first implanted, then gradually erode in a predictable and biocompatible manner.

September 21, 2012 — Endologix Inc. announced this month it received CE mark for the current version of the Nellix EndoVascular Aneurysm Sealing System for the treatment of patients with abdominal aortic aneurysms (AAA).

September 21, 2012 — Following the success of Biotronik’s Pulsar-18 0.018-inch, 4 French platform self-expanding stent system, the company has introduced its Pulsar stent technology in a 0.035-inch, 6 French platform.

September 21, 2012 — Cardionovum GmbH announced that the results of a preclinical study and a first-in-man clinical study of its Primus drug-coated balloon (DCB) will be published in the October issue of Minerva Cardioangiologica, the journal of the Italian Society of Angiology and Vascular Pathology and of the Italian Society of Vascular Diagnostics.

September 20, 2012 — Hospitals, medical facilities, doctors and long-term care facilities this fall are stocking shelves and purchasing items from their wish list and budgets before a new tax on most medical products goes into effect in 2013.

September 20, 2012 — Boston Scientific Corp. has signed a definitive agreement to acquire BridgePoint Medical Inc., a privately held company based in Minneapolis. BridgePoint Medical has developed a proprietary, catheter-based system to treat coronary chronic total occlusions (CTOs).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now